-+ 0.00%
-+ 0.00%
-+ 0.00%

GSK: GSK AND TESARO FIRMLY OF VIEW THAT ALLEGATIONS ARE ENTIRELY WITHOUT MERIT AND REMAIN FOCUSED ON PURSUING THAT CLAIM AT TRIAL

Reuters·04/27/2026 06:00:11

Please log in to view news